HMP Global’s Drug Channels Institute releases ‘2025 Economic Report on U.S. Pharmacies and PBMs,’ examining $683B market

Cover graphic that includes the report title and a conceptual drawing of a pill bottle

This report remains the most comprehensive, fact-based tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system.

New report analyzes market trends, consolidation, and the evolving role of Pharmacy Benefit Managers in the U.S. drug industry.

Consolidation and new partnerships have created vertically integrated organizations that increasingly dominate many aspects of U.S. drug channels. ”

— Drug Channels Institute President Adam J. Fein, Ph.D.

MIAMI, FL, UNITED STATES, March 18, 2025 /EINPresswire.com/ -- Drug Channels Institute (DCI), an HMP Global Company, today released its 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, delving into the crucial commercial, political, financial, and legal forces driving change in the U.S. pharmaceutical market. This report remains the most comprehensive, fact-based tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system.

“In 2024, total prescription dispensing revenues across all retail, mail-order, long-term care, and specialty pharmacies reached $683 billion (excluding COVID-19 vaccines),” said Drug Channels Institute President Adam J. Fein, Ph.D., the study’s author and a widely regarded expert on pharmaceutical economics and the drug distribution system. “Anti-obesity GLP-1 agonist drugs were the most significant driver of prescription revenue at retail pharmacies, accounting for more than 80% of dispensing revenue growth in 2024.”

The report’s release coincides with the inaugural Drug Channels Leadership Forum, under way now at Turnberry Resort and Spa in Miami. Executives from Cencora, Inc., CVS Health, and Eli Lilly and Company are headlining this inaugural event that explores the most pressing strategic issues impacting all participants across U.S. drug channels.

The unique, comprehensive, nonpartisan report analyzes key healthcare trends that affect — and will continue to affect — patients, pharmacy benefit managers, pharmacies, and anyone else seeking to understand and navigate this ever-changing industry. This year’s report incorporates the most current market and industry data available, including DCI’s exclusive analyses of the market positions of leading pharmacies, specialty pharmacies, and PBMs.

Now in its 16th edition, the 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers offers 268 proprietary charts, exhibits, and data tables. It provides the latest economic insights on benefit design, patient out-of-pocket costs, drug pricing, manufacturer rebates, Medicare Part D, Medicaid, the 340B Drug Pricing Program, reimbursement, pharmacy and PBM profits, industry trends, and more.

“Consolidation and new partnerships have created vertically integrated organizations that increasingly dominate many aspects of U.S. drug channels,” Fein added. “Scrutiny of these companies' actions and allegations of anti-competitive behavior will continue to grow.”

Visit drugch.nl/pharmacy to purchase and immediately download the new report. Access a free report overview here.

About Drug Channels Institute
Drug Channels Institute, an HMP Global Company, is a leading source of industry research about pharmaceutical economics and the drug distribution system. DCI helps its customers make sense of pharmaceutical economics and the increasingly complex pharmacy distribution and reimbursement system. To learn more about its products, visit drugchannelsinstitute.com. Access Dr. Fein’s popular Drug Channels blog at drugchannels.net.

About HMP Global
HMP Global is the omnichannel market leader in healthcare events, education, and insight — with a mission to improve patient care. For 40 years, the company has built trusted brands including Psych Congress, the premier source for mental health education, and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP Global partners with leading experts around the world to deliver more than 450 annual events, medical strategy, and marketing for pharmaceutical and medical device customers through HMP Collective, and pharmaceutical market insight, engaging a global community of healthcare stakeholders that includes nearly 2 million clinicians across 600 medical specialties as well as managed care, behavioral health, senior living, emergency medical, and pharmaceutical commercialization professionals. For more information, follow HMP Global on LinkedIn or visit hmpglobal.com.

Sandi Beason, APR
HMP Global
email us here
Visit us on social media:
Facebook
LinkedIn

Distribution channels: Banking, Finance & Investment Industry, Business & Economy, Education, Healthcare & Pharmaceuticals Industry, Insurance Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release